logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-27. All clients under 15, 15-19 and >19 entering treatment in 2005 for those countries supplying data

Age group% <15% 15-19% >19Total
Bulgaria0.39.989.81443
Czech Republic1.223.475.48007
Germany0.613.785.760773
Ireland1.314.983.84671
Greece0.26.992.94248
Spain(1)0.512.287.352731
France0.616.083.420931
Italy0.35.893.948683
Cyprus0.211.888.0423
Lithuania0.14.595.45371
Luxembourg1.013.086.0383
Hungary0.014.086.013835
Malta1.028.071.0500
Netherlands0.48.990.79411
Austria0.04.096.07550
Poland(1)1.019.080.012818
Romania3.016.081.01538
Slovenia(1)0.08.591.52902
Slovakia1.723.275.12078
Finland0.012.088.02935
Sweden0.26.093.86700
United Kingdom1.99.388.8117777
Turkey0.912.686.52038
Total352640263343957387746
%0.910.488.7100.0

Notes:

 Only countries reporting data are included. 

 (1) Last data available for these countries refer to year of treatment 2004.   

 Countries included: BG, CZ, DE, IE, EL, ES, FR, IT, CY, LT, LU, HU, MT, NL, AT, PL, RO, SI, SK, FI, SE, UK, TR. 

 See also 'General notes for interpreting data' on the Explanatory notes and help page

Sources:

 2006 Reitox national reports - standard table 03. 

Page last updated: Monday, 12 November 2007